Prospective study of urinary and sexual dysfunction after surgery for rectal cancer
Not Applicable
- Conditions
- Rectal cancer
- Registration Number
- JPRN-UMIN000010764
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
1.Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma. 2.Uncontrollable diabetes mellitus or routine administration of insulin. 3.Cardiac disease or congestive heart failure that would take medication in order to prevent lethal ventricular arrhythmias. 4.Severe mental disease 5.Doctor' s decision for exclusion
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary and sexual dysfunction
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie urinary dysfunction post-rectal cancer surgery?
How does sexual dysfunction incidence in this trial compare to standard-of-care rectal cancer treatments?
Are there specific biomarkers that predict urinary or sexual dysfunction risk after rectal cancer surgery?
What are the most effective management strategies for post-surgical urinary and sexual dysfunction in rectal cancer patients?
How do surgical techniques for rectal cancer impact long-term urinary and sexual outcomes compared to other interventions?